View Press Releases
-
Genedata Announces Licensing Agreement with Gilead Sciences to Enhance Data Science Innovation in Discovery Research
-
GenHealth.AI Accelerates into Healthcare AI Market with New Funding, Advisor Appointments and Use Cases Across Healthcare
AI Start-up Pioneering Generative AI for Healthcare Receives $13M in Early Funding, Adds Industry Luminaries as Advisors, and Kicks off Use Cases for Health Insurance Plans and Provider Systems
Jul 18, 2023
-
Linus Health Presents New Data on AI-Based Cognitive Assessments at AAIC 2023
Researchers share findings from eight new studies on ability of digital solutions to accelerate early detection of Alzheimer’s and other dementias
Jul 17, 2023
-
Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility
-
BioIVT Acquires PrecisionMed, a Leading Global Provider of Biospecimens for Neurology and Oncology Research
PrecisionMed developed and manages the largest, private, global repository of longitudinally collected human cerebrospinal fluid (CSF) samples for scientific research.
Jul 17, 2023
-
AARDEX Group Announced as Founder Member of CancerX Initiative to Drive Innovation in the Fight Against Cancer
AARDEX Group Announced as Founder Member of CancerX Initiative to Drive Innovation in the Fight Against Cancer Adherence specialists join multi-stakeholder initiative to improve long-term pathways for cancer patients and meet the challenge of oral treatments.
Jul 17, 2023
-
Adlib + Generis Partnership: A “Game Changer” for Regulated Companies
Generis and Adlib Software have announced the launch of a software connector that provides seamless integration between their industry-leading technology platforms.
Jul 18, 2023
-
PromoCell Launches PromoExQ MSC Growth Medium XF for GMP Compliant Isolation and Expansion of Mesenchymal Stem Cells
PromoCell has announced the launch of PromoExQ MSC Growth Medium XF, a serum- and xeno-free cell culture medium designed for GMP-compliant isolation and expansion of mesenchymal stem cells for cell therapy manufacturing applications.
Jul 18, 2023
-
Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers
Acquisition expands customers' ability to accelerate their advanced bioconjugate and payload delivery design innovation
Jul 16, 2023
-
Cytel acquires French group stève consultants to further expand value evidence and real-world analytics capabilities
Cytel Inc. has acquired stève consultants, specialists in market access, real-world (RWE), and health economics and outcomes research (HEOR).
Jul 17, 2023
-
Endor Labs Recognized as a Cool Vendor in the 2023 Gartner® Cool Vendors™ in Platform Engineering for Scaling Application Security Practices
Startup, Endor Labs has been named a Gartner Cool Vendor in Platform Engineering for Scaling Application Security Practices, highlighting the company’s commitment to providing cutting-edge solutions that address the challenges faced by platform engineering and DevSecOps teams in meeting application security needs.
Jul 12, 2023
-
Inizio Engage launches Patient Access Services – an integrated suite of patient support services to enhance access and adherence for specialty therapies
-
DoseMe Expands Leadership Team with Appointments of Paul Edwards to CEO, John Hardesky to CCO and Sharmeen Roy to Chief Strategy & Science Officer
DoseMe, a leading provider of precision dosing software for therapeutic drug monitoring and creators of DoseMeRx and DoseMe Analytics, today announced the appointments of Paul Edwards to Chief Executive Officer, John Hardesky to the role of Chief Commercial Officer and Dr. Sharmeen Roy, PharmD, BCPS, to Chief Strategy and Science Officer.
Jul 12, 2023
-
GigaIO Introduces the First Ever 32 GPU Single-Node Supercomputer for Generative AI and Accelerated Computing
-
Genedata Announces Partnership with Dragonfly Therapeutics to Support Novel Immune Engager R&D
Genedata Biologics supports R&D processes at innovative biopharmaceutical company developing breakthrough immunotherapies for the treatment of cancer and chronic inflammatory diseases
Jul 12, 2023
-
Phastar's B Corp™ certification affirms its status as a 'force for good' organization
Phastar's B Corp™ certification affirms its status as a 'force for good' organization International certification recognizes leading global specialist biometrics CRO’s commitment and leadership in corporate social responsibility and sustainable business practices.
Jul 10, 2023
-
Skyelarke furthers its mission to break down barriers to clinical trial participation, with new SkyePay enhancements
Skyelarke furthers its mission to break down barriers to clinical trial participation, with new SkyePay enhancements Cary, North Carolina- July 11th, 2023: Skyelarke, a health tech company, has announced some significant new additions to SkyePay, a cutting-edge patient payment technology built by and for the clinical research industry.
Jul 10, 2023
-
NCC Group Welcomes New Chief Technology Officer, Siân John
NCC Group, one of the world’s largest security consultancies with over 35 global offices, 2,000 employees in 12 countries and 14,000 clients, today appointed Siân John as Chief Technology Officer. Joining from Microsoft and with 25 years of cybersecurity experience across strategy, business risk, privacy, and technology, Siân will drive innovation, insights and intelligence at the firm through close interaction with clients, industry, and academia.
Jul 10, 2023
-
Cotiviti Introduces Prepay Claim Review Solution for Coordination of Benefits (COB) Validation
New addition to comprehensive COB suite enables health plans to improve claim accuracy while reducing provider and member abrasion
Jul 9, 2023
-
JPA Health Unveils GRETEL Trails: Revolutionizing Integrated Healthcare Marketing with AI-Powered Insight Engine and Chatbot